Neurology

A session on dementia at the BPAO annual health symposium highlighted new research that points to treating AD as a biological disease.

When kids consume caffeine, they don’t necessarily consume it on a regular basis, or in consistent quantities like adults often do.

American College of Physicians issues clinical guidelines on pharmacologic treatments for acute episodic migraine headache in outpatient settings.

Clinicians should discuss risks vs benefits of lecanemab in female patients.

Your dementia patients may be suffering from agitation, depression and related symptoms. Test your knowledge of the latest treatment advice from the Canadian Coalition for Seniors’ Mental Health (CCSMH).

Two drugs sold in the U.S. can modestly slow worsening of early-stage Alzheimer’s by clearing the brain of one of its hallmarks, a sticky gunk called amyloid. But until now, there haven’t been hints that removing amyloid far earlier—many years before the first symptoms appear—just might postpone the disease.

A class of antidepressants may contribute to an increased risk of severe dementia, fracture and death in dementia patients, the new study shows.

Researchers at International Stroke Conference present results showing usual care with thrombolytics has similar outcomes.